A History of Morphine-induced Taste Aversion Learning Fails to Affect Morphine-induced Place Preference Conditioning in Rats
Overview
Social Sciences
Veterinary Medicine
Authors
Affiliations
Drugs of abuse have both rewarding and aversive effects, as indexed by the fact that they support place preferences and taste aversions, respectively. In the present study, we explored whether having a history with the aversive effects of morphine (via taste aversion conditioning) impacted the subsequent rewarding effects of morphine, as measured in the place preference design. In Experiment 1, rats were exposed to a taste aversion procedure in which saccharin was followed by morphine. Place preference conditioning was then initiated in which animals were injected with morphine and placed on one side of a two-chambered apparatus. Animals with a taste aversion history acquired place preferences to the same degree as controls without such a history, suggesting that morphine's affective properties condition multiple effects, dependent on the specific stimuli present during conditioning. To determine whether these results were a reflection of processes operating in traditional associative conditioning, in a modified blocking procedure, place preference conditioning was attempted in the presence of a taste previously associated with morphine (Exp. 2). Under these conditions, animals still acquired morphine-induced place preferences comparable to those of animals without a morphine or conditioning history. These results are consistent with the position that drugs of abuse have multiple stimulus effects (positive and negative) that are differentially associated with specific stimuli (environmental and taste) that drive different behavioral responses (approach and avoidance).
Impact of the Aversive Effects of Drugs on Their Use and Abuse.
Riley A, Manke H, Huang S Behav Neurol. 2022; 2022:8634176.
PMID: 35496768 PMC: 9045991. DOI: 10.1155/2022/8634176.
Nelson K, Manke H, Bailey J, Vlachos A, Maradiaga K, Huang S Pharmacol Biochem Behav. 2021; 211:173286.
PMID: 34634300 PMC: 8643339. DOI: 10.1016/j.pbb.2021.173286.
Ahmadian S, Alaei H, Ghahremani P Adv Biomed Res. 2020; 8:72.
PMID: 32002395 PMC: 6952765. DOI: 10.4103/abr.abr_82_19.
Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").
Riley A, Nelson K, To P, Lopez-Arnau R, Xu P, Wang D Neurosci Biobehav Rev. 2019; 110:150-173.
PMID: 31101438 PMC: 8617600. DOI: 10.1016/j.neubiorev.2018.07.015.
: An Emergent Model for Delineating Interactions between the Circadian Clock and Drugs of Abuse.
De Nobrega A, Lyons L Neural Plast. 2018; 2017:4723836.
PMID: 29391952 PMC: 5748135. DOI: 10.1155/2017/4723836.